KJ Muldoon, who spent nearly the first year of his life being treated at the Children’s Hospital of Philadelphia, is finally home after a gene-editing therapy gave him a second chance at life.

The new artificial blood is shelf stable for two years and can be used on patients of any blood type. Mr. Chiaramonte was an ...

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology—boosting ...

After over two days of continuous protest, Foreign Medical Graduates (FMGs) in Bihar saw a breakthrough as the state health department signed the much ...

A protein that gives fleas their bounce has been used to boot out bacteria cells, with lab results demonstrating the material ...

Discover NIT Rourkela's 2025 innovations: solar water purification, cardiac care advancements, and sustainable food packaging ...

Guardant Health's Shield multi-cancer detection (MCD) test has secured the US Food and Drug Administration’s (FDA) ...

Researchers say they may have found a way to bring a cure for HIV a step closer by deploying the mRNA technology used in ...

The US Food and Drug Administration (FDA) has granted breakthrough device designation to BiVACOR’s titanium Total Artificial ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, ...

Imagine a medical system that embraces doctors’ emotional investment in patients as a strength rather than a liability.